Surgical Innovations Group PLC
02 June 2004
Surgical Innovations Group plc
02 June 2004
AGM statement
At the Annual General Meeting of Surgical Innovations Group plc held today, the
Chairman, Mr Doug Liversidge, made the following statement:
'Since my statement in the Report and Accounts distributed a month ago, I am
pleased to report continuing progress in all areas of the business and am
delighted to announce further strengthening of the strategic relationship with B
Braun AG, under the Aesculap brand.
Yesterday, B Braun Medical Ltd, the UK subsidiary of B Braun AG, signed a 3 year
agreement with the Group for the British distribution rights to Variglide, our
unique, single-use port system. Your Group has been working diligently over
recent months to secure this agreement and we are now able to benefit from the
UK single-use port market, which is valued in excess of £10 million. The
relationship between B Braun Medical Ltd and your Group continues to develop and
as of today, they are now promoting all of our major single-use products, which
will strengthen our position in the home market.
As detailed in the Report and Accounts, we have launched fully disposable
scissors, with complementary single-use instrumentation to be added in due
course. I hope to report shortly on a worldwide distribution agreement with one
of our strategic partners for this line of instrumentation.
Sales in both MIS and ABT continue to improve year on year and this improvement
has been maintained for the first 4 months of 2004. This is testament to the
quality of our product range and the strength of our international distribution
network. We are confident that this growth will be maintained during the
remainder of the year.
Our leasing and banking facilities have recently been re-negotiated and this
will enable us to continue with our programme of essential capital expenditure
and product development.
I look forward to the remainder of 2004 and will report further on our progress
in September when we announce our interim results.'
Enquiries:
Surgical Innovations Group plc Tel: +44 (0) 113 230 7597
Doug Liversidge, CBE, Chairman
Graham Bowland, Finance Director
Westhouse Securities LLP Tel: +44 (0) 161 838 9140
Philip Johnson
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.